Home LiteratureArticle Details
PMID: 9770561 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Parkinson's disease. Second of two parts.

The New England journal of medicine ·Vol. 339 ·No. 16 ·1998-10-15 ·Pages 1130-43

Lang AE, Lozano AM

Abstract

At no time in the past have the basic and clinical sciences applied to Parkinson's disease been so active. Experimental therapies under study at present promise to improve on the limitations of existing treatments. Future progress in understanding the causation and pathogenesis of the disorder will permit the development of new treatments that will slow, halt, or even reverse the currently inexorable progressive course of Parkinson's disease.

MeSH Terms
Antiparkinson Agents/adverse effects,therapeutic use Humans Levodopa/adverse effects,therapeutic use Models, Biological Parkinson Disease/drug therapy,physiopathology,surgery
Chemicals
Antiparkinson Agents Levodopa
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Lang A E
Department of Medicine, University of Toronto and the Toronto Hospital, Canada.
Lozano A M
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1998-10-15
Pages
1130-43
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]